SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-05-000101
Filing Date
2005-02-14
Accepted
2005-02-14 15:10:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 13G HOLDINGS REPORT osi0205.txt SC 13G/A 11732
  Complete submission text file 0001172661-05-000101.txt   13860
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 05608761
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A